Truist Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.67M | Sell |
16,759
-655
| -4% | -$143K | 0.01% | 997 |
|
|
2025
Q1 | $3.9M | Buy |
17,414
+6,650
| +62% | +$1.49M | 0.01% | 929 |
|
|
2024
Q4 | $3.53M | Sell |
10,764
-783
| -7% | -$256K | 0.01% | 974 |
|
|
2024
Q3 | $3.47M | Sell |
11,547
-11,853
| -51% | -$3.56M | 0.01% | 979 |
|
|
2024
Q2 | $7.71M | Sell |
23,400
-4,009
| -15% | -$1.32M | 0.01% | 688 |
|
|
2024
Q1 | $10.8M | Sell |
27,409
-4,929
| -15% | -$1.95M | 0.02% | 597 |
|
|
2023
Q4 | $11.4M | Sell |
32,338
-4,435
| -12% | -$1.56M | 0.02% | 561 |
|
|
2023
Q3 | $13.8M | Sell |
36,773
-2,638
| -7% | -$990K | 0.02% | 482 |
|
|
2023
Q2 | $15.1M | Sell |
39,411
-1,925
| -5% | -$736K | 0.03% | 460 |
|
|
2023
Q1 | $14.3M | Sell |
41,336
-1,172
| -3% | -$406K | 0.02% | 473 |
|
|
2022
Q4 | $10M | Sell |
42,508
-7,650
| -15% | -$1.8M | 0.02% | 565 |
|
|
2022
Q3 | $12.3M | Sell |
50,158
-1,482
| -3% | -$365K | 0.02% | 495 |
|
|
2022
Q2 | $15.6M | Sell |
51,640
-225
| -0.4% | -$68K | 0.03% | 443 |
|
|
2022
Q1 | $21.3M | Sell |
51,865
-1,949
| -4% | -$800K | 0.03% | 409 |
|
|
2021
Q4 | $25.2M | Sell |
53,814
-4,853
| -8% | -$2.28M | 0.04% | 360 |
|
|
2021
Q3 | $24.9M | Sell |
58,667
-4,647
| -7% | -$1.97M | 0.04% | 357 |
|
|
2021
Q2 | $22.7M | Buy |
63,314
+966
| +2% | +$347K | 0.04% | 397 |
|
|
2021
Q1 | $17.6M | Buy |
62,348
+210
| +0.3% | +$59.2K | 0.03% | 452 |
|
|
2020
Q4 | $17.6M | Sell |
62,138
-37,723
| -38% | -$10.7M | 0.03% | 435 |
|
|
2020
Q3 | $27.5M | Sell |
99,861
-39,162
| -28% | -$10.8M | 0.06% | 277 |
|
|
2020
Q2 | $31.6M | Sell |
139,023
-81,058
| -37% | -$18.4M | 0.07% | 254 |
|
|
2020
Q1 | $33.5M | Sell |
220,081
-15,205
| -6% | -$2.32M | 0.09% | 230 |
|
|
2019
Q4 | $35.4M | Buy |
+235,286
| New | +$35.4M | 0.07% | 271 |
|
|
2015
Q4 | – | Sell |
-3,919
| Closed | -$212K | – | 819 |
|
|
2015
Q3 | $212K | Buy |
3,919
+47
| +1% | +$2.54K | 0.01% | 747 |
|
|
2015
Q2 | $225K | Buy |
3,872
+1
| +0% | +$58 | 0.01% | 728 |
|
|
2015
Q1 | $233K | Buy |
+3,871
| New | +$233K | 0.01% | 733 |
|